Solubilizer Captisol enables body to absorb authorized COVID-19 drug therapy

Remdesivir’s formulation includes the solubilizer Captisol, developed at the University of Kansas, which allows remdesivir be administered to the patient. Captisol was invented and patented by Valentino Stella, University Distinguished Professor Emeritus, and Roger Rajewski, research professor in the Department of Pharmaceutical Chemistry.